This study is in progress, not accepting new patients
Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)
Summary
- Eligibility
- for people ages 12 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Incyte Corporation
- ID
- NCT04052425
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated